Adam Leo Stone
Known title: Chief Executive OfficerCIK: 0001727440
Associated companies
Transaction History
| FRNM | ▼ Sell | Other | 2,066,250 | — | 7/20/2026 | View on chart |
| FRNM | ▲ Buy | Grant | 286,250 | $2.9M | 6/13/2024 | View on chart |
| FRNM | ▼ Sell | Other | 2,066,250 | — | 7/20/2026 | View on chart |
| FRNM | ▲ Buy | Grant | 286,250 | $2.9M | 6/13/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Freenome to Present New CRC Data at ACG 2026
Freenome plans to present new validation data for its next-generation colorectal cancer screening test at the ACG 2026 conference. The company will also report its third-quarter 2026 financial results on November 10. These upcoming events provide key updates on the firm's product development and financial performance.
Freenome to Present New CRC Data at ACG 2026. Freenome plans to present new validation data for its next-generation colorectal cancer screening test at the ACG 2026 conference. The company will also report its third-quarter 2026 financial results on November 10. These upcoming events provide key updates on the firm's product development and financial performance.